Literature DB >> 14573764

An N-terminal histidine is the primary determinant of alpha subunit-dependent Cu2+ sensitivity of alphabeta3gamma2L GABA(A) receptors.

Heejeong Kim1, Robert L Macdonald.   

Abstract

Copper (Cu2+) is a physiologically important cation and is released from nerve terminals. Cu2+ modulates GABAA receptor currents in an alpha subunit subtype-dependent manner; alpha1beta3gamma2L receptors are more sensitive to Cu2+ than alpha6beta3gamma2L receptors. We compared the effect of Cu2+ on alphabeta3gamma2L receptors containing each of the six alpha subtypes and generated alpha1/alpha6 chimeras and mutants to determine the functional domain(s) and specific residues responsible for alpha subtype-dependent differences in Cu2+ sensitivity. Whole-cell GABAA receptor currents were obtained from L929 fibroblasts coexpressing wild-type, chimeric and mutant alpha subunits with beta3 and gamma2L subunits. Maximal Cu2+ inhibition of alpha1beta3gamma2L and alpha2beta3gamma2L receptor currents was larger (52.2 +/- 3.0 and 59.0 +/- 2.5%, respectively) than maximal inhibition of alpha3beta3gamma2L, alpha4beta3gamma2L, alpha5beta3gamma2L, and alpha6beta3gamma2L receptor currents (22.6 +/- 3.1, 19.2 +/- 3.4, 20.2 +/- 4.8, and 21.2 +/- 3.6%, respectively). Receptors containing chimeric constructs with alpha1 subtype N-terminal sequence between residues 127 and 232 were inhibited by Cu2+ to an extent similar to those with alpha1 subtypes, suggesting that this N-terminal region (127-232) contains a major determinant for high Cu2+ sensitivity. alpha1 subtype residues V134, R135, and H141 in a VRAECPMH motif (VQAECPMH in the alpha2 subtype) conferred higher Cu2+ sensitivity, and the H141 residue was the major determinant in the motif. The beta3 subtype M2 domain residue H267, which is a major determinant of Zn2+ inhibition, and alpha6 subtype M2-M3 loop residue H273, which is responsible for the increased Zn2+ sensitivity of the alpha6 subtype, also seemed to contribute to Cu2+ inhibition. These data suggest that the N-terminal VR(Q)AECPMH motif in alpha1 and alpha2 subtypes is the major determinant of increased subtype-dependent inhibition by Cu2+, that residue H141 is the major determinant in that motif, and that Cu2+ may also interact with GABAA receptors at sites similar to or overlapping Zn2+ sites.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573764     DOI: 10.1124/mol.64.5.1145

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  12 in total

1.  In vivo and in vitro analyses of amygdalar function reveal a role for copper.

Authors:  E D Gaier; R M Rodriguiz; J Zhou; M Ralle; W C Wetsel; B A Eipper; R E Mains
Journal:  J Neurophysiol       Date:  2014-02-19       Impact factor: 2.714

2.  Loss of divalent metal transporter 1 function promotes brain copper accumulation and increases impulsivity.

Authors:  Murui Han; JuOae Chang; Jonghan Kim
Journal:  J Neurochem       Date:  2016-07-22       Impact factor: 5.372

Review 3.  Copper signaling in the mammalian nervous system: synaptic effects.

Authors:  E D Gaier; B A Eipper; R E Mains
Journal:  J Neurosci Res       Date:  2012-11-01       Impact factor: 4.164

4.  Plasma copper and zinc concentration in individuals with autism correlate with selected symptom severity.

Authors:  Anthony J Russo; Andrea P Bazin; Richard Bigega; Robert S Carlson; Martin G Cole; Dilenia C Contreras; Matthew B Galvin; Sayde S Gaydorus; Sierra D Holik; Gavin P Jenkins; Brandon M Jones; Penelope A Languell; Padraic J Lyman; Kareem P March; Katie A Meuer; Serena R Peterson; Matthew T Piedmonte; Michael G Quinn; Nicole C Smaranda; Patrick L Steves; Heather P Taylor; Teagan E Waddingham; Janine S Warren
Journal:  Nutr Metab Insights       Date:  2012-02-28

5.  Analysis of Copper and Zinc Plasma Concentration and the Efficacy of Zinc Therapy in Individuals with Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and Autism.

Authors:  A J Russo; Robert Devito
Journal:  Biomark Insights       Date:  2011-11-08

6.  Identification of amino acids involved in histamine potentiation of GABA A receptors.

Authors:  Ulrike Thiel; Sarah J Platt; Steffen Wolf; Hanns Hatt; Günter Gisselmann
Journal:  Front Pharmacol       Date:  2015-05-26       Impact factor: 5.810

Review 7.  Copper and copper proteins in Parkinson's disease.

Authors:  Sergio Montes; Susana Rivera-Mancia; Araceli Diaz-Ruiz; Luis Tristan-Lopez; Camilo Rios
Journal:  Oxid Med Cell Longev       Date:  2014-01-08       Impact factor: 6.543

8.  Copper block of extrasynaptic GABAA receptors in the mature cerebellum and striatum.

Authors:  Thomas P McGee; Catriona M Houston; Stephen G Brickley
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

9.  Analysis of plasma zinc and copper concentration, and perceived symptoms, in individuals with depression, post zinc and anti-oxidant therapy.

Authors:  A J Russo
Journal:  Nutr Metab Insights       Date:  2011-04-17

10.  Increased Copper in Individuals with Autism Normalizes Post Zinc Therapy More Efficiently in Individuals with Concurrent GI Disease.

Authors:  Anthony J Russo
Journal:  Nutr Metab Insights       Date:  2011-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.